Geode Capital Management LLC recently announced the acquisition of new stake in ASP Isotopes Inc (NASDAQ:ASPI). This fresh investment now brings its stake to 0.21% valued currently at $0.19 million. In addition, Northern Trust Investments, Inc. raised its holdings by 22151.0 to 22151.0 shares.
With over 0.46 million ASP Isotopes Inc (ASPI) shares trading Friday and a closing price of $1.99 on the day, the dollar volume was approximately $0.92 million. The shares have shown a positive half year performance of 221.49% and its price on 01/12/24 gained nearly 2.05%. Currently, there are 35.91M common shares owned by the public and among those 23.17M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 11 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 11 of these insider trades were purchases, accounting for 1,909,928 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in ASP Isotopes Inc are Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Fidelity Nasdaq Composite Index F. Vanguard Extended Market Index Fu owns 0.16 million shares of the company’s stock, all valued at over $0.28 million. The company bought an additional 0.13 million shares recently to bring their total holdings to about 0.32% of the shares outstanding. Fidelity Nasdaq Composite Index F bought 12220.0 shares to bring its total holdings to over 27092.0 shares at a value of $48495.0. Fidelity Nasdaq Composite Index F now owns shares totaling to 0.06% of the shares outstanding.
Shares of ASP Isotopes Inc (NASDAQ: ASPI) opened at $2.03, up $0.08 from a prior closing price of $1.95. The company’s stock has a 5-day price change of 13.71% and 80.91% over the past three months. ASPI shares are trading 11.17% year to date (YTD), with the 12-month market performance up to 20.24% higher. It has a 12-month low price of $0.28 and touched a high of $2.20 over the same period. ASPI has an average intraday trading volume of 232.15K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.17%, 17.57%, and 90.94% respectively.
Institutional ownership of ASP Isotopes Inc (NASDAQ: ASPI) shares accounts for 0.63% of the company’s 35.91M shares outstanding. Mutual fund holders own 0.58%, while other institutional holders and individual stakeholders account for 36.11% and 0.05% respectively.
It has a market capitalization of $97.05M and a beta (3y monthly) value of 4.70. The earnings-per-share (ttm) stands at -$0.44. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.17% over the week and 7.16% over the month.
Analysts forecast that ASP Isotopes Inc (ASPI) will achieve an EPS of $CSP Inc. for the current quarter, $20.83 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Altisource Portfolio Solutions while analysts give the company a high EPS estimate of $ASP Isotopes Inc.. Comparatively, EPS for the current quarter was $Sendas Distribuidora S A a year ago.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate ASP Isotopes Inc (ASPI) as a “Strong Buy” at a consensus score of 1.00. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the ASPI, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on December 05, 2023, with the firm’s price target at $3.25.
